ArticleInternational journal of hematology2016

Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.

Kaito Harada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.